Table 2. Human AChR gating and binding free energy changes.
| Site | Agonist | ΔG1 | ΔGR | ΔGR* |
|---|---|---|---|---|
| α–ε | ACh | 2.8 | −5.6 | −11.2 |
| CCh | 3.3 | −5.1 | −10.4 | |
| TMA | 3.7 | −4.4 | −9.1 | |
| Cho | 5.1 | −3.4 | −6.7 | |
| α–δ | ACh | 3.2 | −5.3 | −10.5 |
| CCh | 3.8 | −4.6 | −9.2 | |
| TMA | 4.2 | −4.2 | −8.5 | |
| Cho | 5.5 | −3.2 | −6.1 | |
| α–δ | Epi | 3.7 | −7.0 | −11.7 |
| Ebx | 4.0 | −5.9 | −10.4 | |
| Anx | 4.8 | −5.0 | −8.7 | |
| Aza | 5.4 | −4.1 | −7.1 | |
| α–γ | ACh | 1.7 | −5.2 | −13.1 |
| CCh | 2.9 | −5.4 | −12.1 | |
| TMA | 3.7 | −4.7 | −10.6 | |
| Cho | 4.6 | −4.1 | −9.0 |
All values are kilocalories per mole. ΔG1, gating with one bound agonist; ΔGR, binding to the resting conformation; ΔGR*, binding to the active conformation (Fig. 1 b).